UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C.   20549


                                 FORM 10-QSB
                 Quarterly Report Under Section 13 or 15(d)
                   of the Securities Exchange Act of 1934.


For the quarter ended  March 31, 2000   Commission file number   000-25523




                         ANONYMOUS DATA CORPORATION
           (Exact name of registrant as specified in its charter)



Nevada                                                 86-0857752
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                         Identification No.)

6170 W. Desert Inn
Las Vegas, Nevada                                      89146
(Address of principal executive offices)               (Zip Code)


                               (702) 221-0756
             Registrant's telephone number, including area code


     Indicate by check mark whether the registrant (1) has filed all  reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during  the  preceding 12 months (or for such shorter period  that  the
registrant  was required to file such reports), and (2) has been  subject  to
such filing requirements for the past 90 days.

                          Yes               No    X


     As of March 31, 2000, there were 11,530,660 shares of common stock
                                outstanding.

<PAGE>

                         ANONYMOUS DATA CORPORATION
                            FOR THE QUARTER ENDED
                               MARCH 31, 2000


                                    INDEX

PART I - FINANCIAL INFORMATION                              Page No.

     Item 1.   Financial Statements

               Balance Sheets as of March 31, 2000                    3
               and December 31, 1999

               Statement of Stockholders' Equity
               for the three months ended March 31, 2000              4

               Income Statements for the three-month period
               ended March 31, 2000 and March 31, 1999                5

               Statements of Cash Flow for the three-month            6
               period ended March 31, 2000 and March 31, 1999

     Item 2.   Management's Discussion and Analysis of
               Financial Condition and Results of Operation           7-10


PART II - OTHER INFORMATION

     Item 1.   Legal Proceedings                                      9

     Item 2.   Changes in Securities                                  9

     Item 3.   Defaults by the Company upon its
               Senior Securities                                      9

     Item 4.   Submission of Matter to a Vote of
               Security Holders                                       10

     Item 5.   Other Information                                      10

     Item 6.   Exhibits and Reports of Form 8-K                       10

     SIGNATURES                                                       11

<PAGE>
<TABLE>

                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                               BALANCE SHEETS
                    MARCH 31, 2000 AND DECEMBER 31, 1999

                       PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
                                   ASSETS
                                        March 31, 2000      December, 31, 1999
                                           (unaudited)
<S>                                   <C>                   <C>
Current assets:
  Cash                                       $   18,071            $  3,939
  Prepaid expenses                              646,920
                                      -----------------     ----------------
                                                664,991               3,939

 Furniture, fixtures and equipment              127,930             125,449
 Accumulated depreciation                       (36,224)            (36,224)
                                      -----------------     ----------------
                                                 91,706              89,225

Unamortized patent costs                         96,415              96,038
                                     ------------------      --------------
                                               $853,112             189,202
                                      ================      ===============
</TABLE>
<TABLE>
                    LIABILITIES AND STOCKHOLDERS' EQUITY
<S>                                 <C>                   <C>
Current liabilities:
 Accounts payable                           $   37,190              37,569
 Payroll taxes payable                           7,089               7,089
 Accrued interest, officer                       5,100               5,100
 Other                                             605               1,528
                                      ----------------      --------------
                                                49,984              51,286
Long-term debt, officer                        148,000              51,000
                                      ----------------      --------------
Total liabilities                              197,984             102,286
                                     -----------------      --------------
Stockholders' equity:
 Common stock, $.001 par, 100,000,000 shares
 authorized, 11,531,000 shares issued and
 outstanding                                    11,531               9,438

 Preferred stock, $.001 par, 25,000,000 shares
 authorized, none issued and outstanding

 Additional paid-in capital                  4,738,664           1,692,376

 Deficit accumulated during
development stage                           (4,095,067)         (1,614,898)
                                      ----------------      --------------
                                               655,128              86,916
                                      ----------------      --------------
                                              $853,112            $189,202
                                              ======              =======
</TABLE>
<PAGE>
<TABLE>


                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)
                 FOR THE THREE MONTHS ENDING MARCH 31, 2000


                         Common Stock        Additional   Accumulated
                    Shares       Par Value  Paid-In Capital Deficit    Total
                   -----------   --------   -----------  ----------  --------
<S>                <C>          <C>        <C>         <C>           <C>
Balance 12-31-99    $9,438,160     $9,438    $1,692,376 $(1,614,898)  $86,916
Shares Issued To:
  Consultants for
services             2,092,500      2,093     3,046,288             3,048,381
 Net loss                                                (2,480,169)(2,480,169)
                   -----------     ------   -----------  ----------  ---------
Balance 3-31-00    $11,530,660    $11,531    $4,738,664 $(4,095,067)  $655,128
                    ==========  =========    ==========    ========   ========
</TABLE>
<PAGE>
<TABLE>
                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                              INCOME STATEMENTS
     FOR THE THREE MONTH PERIODS ENDED MARCH 31, 2000 AND MARCH 31, 1999
                                 (unaudited)


                                               2000              1999
<S>                                         <C>             <C>
Operating costs and expenses:

  Research and development                    $2,407,311         $217,642

  Administrative                                  75,333          335,464
                                             -----------     ------------
                                               2,482,644          553,106
                                             -----------    -------------

Income, other                                      2,475            1,510
                                             -----------     ------------
Net loss                                     $(2,480,169)       $(551,596)
                                             ------------   -------------

Loss per share                                     (0.24)           (0.06)
                                               =========         =========
Weighted average of number of shares
outstanding                                   10,386,077        9,079,260
                                               =========         =========
</TABLE>
<PAGE>
<TABLE>
                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                          STATEMENTS OF CASH FLOWS
        FOR THE THREE MONTHS ENDING MARCH 31, 2000 AND MARCH 31, 1999

                                                  2000           1999
                                              (unaudited)
<S>                                           <C>            <C>
Operating activities:

       Net loss                                 $(2,480,169)       $(551,596)

       Expenses reimbursed with stock             3,048,381          376,210

     Change in operating assets:

       Increase in employee advances                                 (2,300)

       Increase in prepaid expenses                (646,920)         (2,750)

       Decrease in deferred offering costs                          144,000

     Change in operating liabilities:

       Decrease in accounts payable                   (378)
                                           ----------------       ----------
     Net cash used by operating activities         (79,086)          (36,436)
                                           ---------------    --------------
     Investing activities:

       Purchase of equipment                        (2,481)           (6,025)

       Patent costs                                   (377)          (12,988)
                                           ---------------     --------------
       Net cash used in investing activities        (2,858)          (19,013)
                                           ---------------      ------------
     Financing activities:

       Payments on lease purchase obligation         (924)            (1,757)

       Sale of common stock                                          365,250

       Loan from principal shareholder             97,000
                                             ------------      -------------
       Net cash provided by financing
     activities                                    96,076            363,493
                                             ------------     --------------

     Net increase in cash                          14,132            308,044

     Cash, beginning                                3,939             13,793
                                             ------------     --------------
     Cash, ending                                  18,071            321,837
                                            =============      =============
</TABLE>
<PAGE>


                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                        NOTES TO FINANCIAL STATEMENTS

1.   Summary of significant accounting policies:

   Nature  of  business.  The Company is a development stage enterprise  and,
   therefore,  as  of March 31, 2000, has not commenced business  operations.
   The  Company  was  incorporated in 1996, for  the  purpose  of  developing
   biometric  equipment and related software to store and  retrieve  date  of
   medical   laboratory  testing.   The  Company  is  in  the  research   and
   development  phase of testing its technical equipment and  software.   The
   Company's future operations could be affected by adverse changes in  local
   and national economic conditions.  (See Note 3.)

   Basis of presentation. The accompanying unaudited consolidated financial
   statements have been prepared in accordance with generally accepted
   accounting principles for interim financial information and the
   instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly,
   they do not include all of the information and disclosures required by
   generally accepted accounting principles for annual financial statements.
   In the opinion of management, all adjustments (consisting only of normal
   recurring adjustments) considered necessary for a fair presentation have
   been included.  The results of operations for any interim period are not
   necessarily indicative of results for the full year.  For further
   information, please refer to the financial statements of Anonymous Data
   Corporation (the "Company"), and the related notes, included within the
   Company's Annual Report on Form 10-K for the fiscal year ended December
   31, 1999 (the "1999 Form 10-K"), previously filed with the Securities and
   Exchange Commission.

   Offering costs.  The Company has offered its unregistered common stock  to
   the  public in offerings intended to be exempt from registration with  the
   United  States Securities and Exchange Commission (SEC) pursuant  to  Rule
   504  promulgated  under  the Securities Act of 1933.   The  costs  of  the
   offerings have been offset against the proceeds to date.

   Use   of  estimates.   Timely  preparation  of  financial  statements   in
   conformity   with   generally  accepted  accounting  principles   requires
   management to make estimates and assumptions that affect reported  amounts
   and disclosures, some of which may require revision in future proceeds.

   Equipment,  depreciation and amortization.  Equipment is stated  at  cost.
   Depreciation  and amortization is provided by an accelerated  method  over
   the estimated useful live of the assets.

   Stock  compensation awards.  The company has adopted Financial  Accounting
   Standard  Board Statement No. 123 Accounting for Stock-Based Compensation,
   for valuing compensatory stock and option awards.  (See Note 5.)

   Patent  costs.   Cost  associated with patents  and  patents  pending  are
   deferred  and  amortized based on the lives of patents  granted.   In  the
   event  patent applications are denied or abandoned, such costs are written
   off.   For  patents granted late in the year, amortization begins  in  the
   following year.
<PAGE>

                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                  NOTES TO FINANCIAL STATEMENTS (CONTINUED)


1.      Summary of significant accounting policies (Continued):

   Loss  per share.  Loss per share is computed based on the weighted average
   number of shares outstanding for the periods presented.

2.   Related party transactions:

   Dr.  James  E.  Beecham (Chairman of the Board of Directors  and  majority
   shareholder and president of the Company) has licensed to the Company  the
   rights  associated  with  two  U.S. patents  pending.   The  licenses  are
   irrevocable  until May 14, 2008.  Dr. Beecham has also  agreed  to  extend
   the  licenses  for  an additional eight years depending upon  performance.
   In consideration for the assignment of rights, Dr. Beecham will receive  a
   royalty of 3% of the first $10 million, 2% of $10 to $25 million,  and  1%
   in  excess  of  $25  million in gross revenues to  the  Company  from  the
   manufacture, use, sale or operation of the products and services.

   The Chairman has loaned the Company  an additional $97,000 for a total  of
   $148,000  dollars  at 10% annually.  Interest payments  are  due  annually
   with  principal  balance  due in its entirety at the  five  year  maturity
   date.

   During  early 1999, the Company issued 129,500 shares of its common  stock
   valued at $1 per share to its officers/directors as compensation.

3.   Prepaid expenses:

   Prepaid expenses represents the unamortized portion of future services  to
   be  rendered  through  January 31, 2001 by consultants  who  received  the
   Company's        common       shares       for       such         services
                                                         $646,920
                                                          =======

4.   Going concern contingency:

   The   Company's  ability  to  complete  certain  research   projects   and
   development  of  its equipment and software development is dependent  upon
   obtaining  additional  equity  or debt financing.   This  condition  could
   prevent the Company from commencing business operations and continuing  as
   a  going  concern.  The balance sheet, however, has been prepared assuming
   the  Company  will  continue  as  a going  concern,  and  it  reflects  no
   adjustments  that  might  result from the  outcome  of  this  uncertainty.
   However,  because  of this uncertainty, no effect has been  given  in  the
   balance  sheet  to any future income tax benefit of the loss  recorded  to
   date.  The Company has a net operating loss carryforward expiring in  year
   2019  available  to  reduce future income tax expense  in  the  amount  of
   approximately $1,600,000.
<PAGE>


4. Going concern contingency (Continued):

   Management  expects  to raise additional equity capital  by  offering  its
   common  stock  for  sale  to investors through  private  placement  or  by
   registration with the SEC under the Securities Act of 1933 or obtain  debt
   financing  to complete its research projects and equipment and obtain  the
   related   additional  patents.   Management  expects  that  the  Company's
   medical data management equipment, when completed, will have a wide  range
   of  applications in medical testing data storage.  Management's ability to
   effectively  implement its plans could have a material and adverse  effect
   upon the Company's business, financial condition and future operations.

<PAGE>

Item 2.    Management's Discussion and Analysis of Financial Condition and
          Results of Operations.

    The  following discussion and analysis should be read in conjunction with
the  Company's financial statements and the notes thereto contained elsewhere
in this filing.

Overview

     Anonymous  Data  Corporation, a Nevada corporation  (the  "Company"  or
"ADC") formed in November 1996, is a development stage enterprise engaged in
the business of data management using a biometric identification system. The
biometric  identification  system; (i) archives  individual  data,  such  as
medical  educational  information, for access by  registered  users  through
rapid  sorting using scanning of a portion of their anatomy as a preliminary
search  method;  and,  (ii)  permits a second method  of  identification  of
individuals volunteering for payment as plasma donors.

Background

     We  have obtained rights to a method of linking files of archived  data
to the anatomy of an individual.  This method allows the search function for
records  to be more rapid and accurate and re-checked according to the  name
of  the  individual. We have spent $281,438 during 1999 toward research  and
development   toward  the  refinement  of  our  biometric  individual   data
identification system.

     The  term  BIOMETRIC derives from the words body (BIO) and  measurement
(METRIC).  The  science  of  biometrics has in recent  years  developed  the
technology  to  take a reading from a human (such as electronic  scan  of  a
fingerprint, iris scan, facial recognition, palm print, voice sample,  etc).
The  electronic  scan  is then matched with the same  biometric  marker  for
purposes  of  recognition and verification of identity.  The  United  States
Patent  and  Trademark Office has issued two U.S. patents to  Dr.  James  E.
Beecham, Chairman of the Company. The Patents, Patent Numbers U.S. 5,876,926
[PCT/U.S.  98/16435]) and U.S. 5,897,989 [PCT/U.S. 97/08015], pertain  to  a
method,  system  and apparatus that permit an individual to submit  biologic
test  specimens  for  medical  testing under biometric  identification.  The
system  then  allows  for the subsequent retrieval of test  results  from  a
computerized  database utilizing the same biometric personal identification.
These  Patents have been exclusively licensed to us from Dr. Beecham. -  See
"Certain Transactions - License Agreement."

     The  patented applications, in non-U.S. territories, will  be  utilized
for collecting medical specimens in containers labeled by "biometric index".
For  example,  a  biometric  index  may be  obtained  from  the  scan  of  a
fingerprint  and/or the scan of the iris of the eye of the  specimen  donor.
After   testing  in  a  certified  laboratory,  the  test  data  is   stored
electronically under linkage to that same personal biometric  index.  Access
to  such "biometrically" stored information is controlled by the re-scan  of
the specimen donor. Since viewing the data requires "unlocking" the computer
file by scanning the same fingerprint and/or eye as was used for sending the
specimen  to  the  lab  in the first place, our system provides  the  secure
protection of the donors sample and limits mistakes that are sometimes  made
in the donation process.
<PAGE>

     We  have developed a plan and are in the process of developing a  method
for  providing services and products worldwide based on our exclusive  patent
licenses.  We  plan to offer these products as turnkey systems  and  also  to
offer services directly to subscribers domestically and abroad

Results  of Operations for the three months ended March 31, 2000  and  March
31, 1999
(unaudited)

     Total operating expenses from continuing operations were $2,482,644  for
the  three  months ended March 31, 2000 compared to $553,106  for  the  three
months  ended March 31, 1999.  Operating expenses for the three months  ended
March  31,  2000 includes $2,401,997 expense related to the value of  Company
shares  issued  to  consultants for services.   Utilizing  an  average  daily
calculation of operating expenses of $27,282 for the period ending March  31,
2000,  and  an average daily calculation of operating expenses of $6,146  for
the period ending March 31, 1999, this represented a 588% increase in average
daily operating expenses.

Forward-Looking Statements and Associated Risks

     This Quarterly Report on Form 10-QSB contains forward-looking statements
made  pursuant  to  the  safe harbor provisions of the Securities  Litigation
Reform  Act  of 1995.  These forward looking statements are based largely  on
the  Company's  expectations  and  are subject  to  a  number  of  risks  and
uncertainties, many of which are beyond the Company's control, including, but
not  limited  to,  economic,  competitive and  other  factors  affecting  the
Company's  operations, markets, products and services,  expansion  strategies
and  other factors discussed elsewhere in this report and the documents filed
by  the  Company with the Securities and Exchange Commission.  Actual results
could  differ materially from these forward-looking statements.  In light  of
these  risks  and uncertainties, there can be no assurance that the  forward-
looking  information  contained in this report will in fact  prove  accurate.
The Company does not undertake any obligation to revise these forward-looking
statements to reflect future events or circumstances.

Liquidity and Capital Reserves

As of March 31, 2000 and March 31, 1999 (Unaudited)

     As  of  March  31,  2000,  the Company's assets were  $853,112  and  its
liabilities were $197,984, resulting in an excess of assets of $655,128.  The
assets  include  prepaid  expenses of $646,920 representing  the  unamortized
portion  of  future  services  to be rendered through  January  31,  2001  by
consultants who received the Company's common shares for such service.   Cash
was  $18,071 at March 31, 2000 as compared to cash of $324,137 on  March  31,
1999,  a  decrease of $306,066. This represented a 94% decrease in  available
cash.  This  decrease  was primarily the result of an increase  in  operating
expenses.

     The  Company  has continued to fund its deficit cash flow  from  private
placements  of the Company's common stock. It is anticipated that  loans  and
the  sale of the Company's stock will continue until such time as the Company
generates   sufficient  revenues  from  its  operations  to  cover  operating
expenses.

<PAGE>
PART II--OTHER INFORMATION

Item 1.       Legal Proceedings.

     The  Company recently settled a suit filed on January 14, 2000  by  Asia
Pacific,  Inc., a Nevada Corporation, dba Laser Barcode Solutions, which  was
filed  in  District  Court  in  Clark County,  Nevada,  Case  Number  A413603
Department  XII  against Anonymous Data Corporation and the  President  James
Beecham  claiming  Breach  of  Contract,  Tortious  Breach  of  Contract  and
Negligent/Intentional Misrepresentation.

Item 2.       Changes in Securities.

     None.

Item 3.       Defaults by the Company upon its Senior Securities.

     None.
Item 4.       Submission of Matter to a Vote of Security Holders.

     None

Item 5.       Other Information.

     None

Item 6.       Exhibits and Reports of Form 8--K.

     None
<PAGE>
                                 SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant  has  duly caused this report to be signed on its  behalf  by  the
undersigned, thereunto duly authorized.


ANONYMOUS DATA CORPORATION
(Registrant)



By:/s/ James Beecham
    James E. Beecham
     President

Date: May 19, 2000